Steven Magnuson
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Prostate Cancer Treatment and Research, Ubiquitin and proteasome pathways, Multiple Myeloma Research and Treatments, Histone Deacetylase Inhibitors Research
Most-Cited Works
- → Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation(2018)408 cited
- → A Novel Tankyrase Small-Molecule Inhibitor Suppresses APC Mutation–Driven Colorectal Tumor Growth(2013)318 cited
- → Two-directional synthesis and its use in natural product synthesis(1995)209 cited
- → Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors(2015)188 cited
- → Modulators of the Nuclear Receptor Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc)(2014)164 cited
- → Therapeutic Targeting of the CBP/p300 Bromodomain Blocks the Growth of Castration-Resistant Prostate Cancer(2017)149 cited
- → A TRPA1 inhibitor suppresses neurogenic inflammation and airway contraction for asthma treatment(2021)130 cited
- → GNE-781, A Highly Advanced Potent and Selective Bromodomain Inhibitor of Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP)(2017)126 cited
- → A Restricted Role for TYK2 Catalytic Activity in Human Cytokine Responses Revealed by Novel TYK2-Selective Inhibitors(2013)125 cited
- → Pharmacological Inhibition of the Histone Lysine Demethylase KDM1A Suppresses the Growth of Multiple Acute Myeloid Leukemia Subtypes(2016)123 cited